| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
| filingDate |
2009-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0a47ef7a85f6838b34f6061dad6c157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d596592308329720bb403c5b4ca3c6c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b7ed59bd0a5dc86c58c16b095a75648
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a54720073efd26e6542bcdf0e1ad21fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1eba0abb3a4cecf3b9b7048492f542a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02f0068b228277c556a05dcbbe42d57f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93de87974c6f1be52728e609505f19da |
| publicationDate |
2011-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110038671-A |
| titleOfInvention |
Azole compounds |
| abstract |
The present invention provides a compound useful as an active ingredient of a pharmaceutical composition for treating neuropathic pain. As a result of earnestly examining compounds having FAAH inhibitory activity, the inventors have found that an azole compound substituted with an N- (pyridin-3-yl) oxycarbonyl-piperidin-4-yl group and a phenyl group or a pharmaceutically acceptable compound thereof. The present invention was completed by finding that salts exhibited excellent FAAH inhibitory activity. The compound of the present invention is useful as a prophylactic and / or therapeutic agent for neuropathic pain because it has excellent FAAH inhibitory activity and can identify anti-allodynia effects in a rat neuropathic pain model. |
| priorityDate |
2008-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |